Gabelli & Co Investment Advisers’s Cross Country Healthcare CCRN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$730K	Sell	77,650 -70,050	-47%	-$627K	0.11%	141
2025 Q4	$1.2M	Sell	147,700 -89,150	-38%	-$974K	0.18%	103
2025 Q3	$3.36M	Sell	236,850 -178,300	-43%	-$2.35M	0.54%	40
2025 Q2	$5.42M	Sell	415,150 -20,850	-5%	-$287K	0.83%	36
2025 Q1	$6.49M	Buy	436,000 +146,850	+51%	+$2.52M	0.98%	28
2024 Q4	$5.25M	Buy	+289,150	New	+$3.89M	0.9%	32

Other funds holding CCRN

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

DIA

Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Gabelli & Co Investment Advisers's CCRN Position: Q1 2026 in Review

Gabelli & Co Investment Advisers reduced its Cross Country Healthcare (CCRN) stake by 47% in Q1 2026, selling an estimated $627K and leaving 77,650 shares worth $730K. The position accounts for 0.11% of the portfolio, ranked #141.

Gabelli & Co Investment Advisers first reported a position in CCRN in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.49M in Q1 2025. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

Gabelli & Co Investment Advisers held 77,650 shares of Cross Country Healthcare worth $730K as of Q1 2026.
Gabelli & Co Investment Advisers sold 70,050 Cross Country Healthcare shares in Q1 2026, an estimated $627K.
Cross Country Healthcare made up 0.11% of Gabelli & Co Investment Advisers's portfolio in Q1 2026, its #141 holding.
Gabelli & Co Investment Advisers first reported a position in Cross Country Healthcare in Q4 2024 and has held it in 6 quarters since.
Gabelli & Co Investment Advisers's Cross Country Healthcare position peaked at $6.49M in Q1 2025.
151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.